Cabio Biotech (Wuhan) Co Company Profile - aVenture Research
CABIO Biotech traces its origins to fermentation technology and has grown into a multi-category ingredients business whose products reach human nutrition, animal nutrition, and personal care. Its predecessor Alking Bioengineering commercialized a fermentation-based UFA production process and was the first microbial oil refiner in China to launch arachidonic acid products. Its NeoHMOs are approved for use in China and comply with all EU standards.
The company has achieved the industrialization of arachidonic acid, DHA, beta-carotene, and N-acetylneuraminic acid, produced through a process covering strain breeding, cell regulation, and separation and purification. It serves developers of nutrition and health foods worldwide. With Nourish Ingredients, it completed the world's first commercial production of precision fermentation-derived fats.
Cabio Biotech, STAR Market-listed biotechnology company, industrializes arachidonic acid, DHA, beta-carotene and other products for nutrition and health food developers.